Hong Kong stocks surged again | Xinda Biosciences (01801.HK) rose by over 4% IBI363 and IBI343 research data impressive, Morgan Stanley raised sales forecast.

According to the Wisdom Financial APP, Shinda Biotechnology (01801.HK) has surged by over 4% again, rising by 4.44% to 65.9 Hong Kong dollars as of the writing of this report, with a turnover of 1.259 billion Hong Kong dollars.